Breaking News Instant updates and real-time market news.

ITRM

Iterum Therapeutics

$1.23 /

+0.045 (+3.80%)

17:03
05/27/21
05/27
17:03
05/27/21
17:03

Iterum Therapeutics provides update on NDA review

Iterum Therapeutics announced that the company participated in a late-cycle meeting with the FDA yesterday. During the meeting, the FDA shared issues still under review regarding the company's new drug application, NDA, for sulopenem etzadroxil/probenecid for the treatment of uncomplicated urinary tract infections in patients with a quinolone non-susceptible pathogen and the company responded to these issues. The FDA has determined that an advisory committee meeting is not currently necessary. The review of the NDA is ongoing and the company was informed that the FDA continues to work toward the PDUFA goal date of July 25, 2021.

  • 25

    Jul

ITRM Iterum Therapeutics
$1.23 /

+0.045 (+3.80%)

03/15/21 H.C. Wainwright
Iterum Therapeutics upgraded to Buy from Neutral at H.C. Wainwright
12/24/20 H.C. Wainwright
Iterum CSO resignation 'somewhat troubling,' says H.C. Wainwright
06/16/20 H.C. Wainwright
Iterum Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
06/02/20 RBC Capital
Iterum Therapeutics downgraded to Sector Perform from Outperform at RBC Capital

TODAY'S FREE FLY STORIES

General news
May durable goods core capital goods down 0.1% vs. last month, consensus 0.5%  08:47
06/24/21
06/24
08:47
06/24/21
08:47
$ECON

Economic Data

/

+

 
ShowHide Related Items >><<
$ECON Economic Data
/

+

General news
May durable goods ex-transportation up 0.3% vs. last month, consensus 0.7%  08:47
06/24/21
06/24
08:47
06/24/21
08:47
$ECON

Economic Data

/

+

 
ShowHide Related Items >><<
$ECON Economic Data
/

+

General news
May durable goods new orders up 2.3% vs. last month, consensus 2.0%  08:47
06/24/21
06/24
08:47
06/24/21
08:47
$ECON

Economic Data

/

+

 
ShowHide Related Items >><<
$ECON Economic Data
/

+

General news
Q1 GDP quarter-over-quarter up 6.4%, consensus 6.4%  08:47
06/24/21
06/24
08:47
06/24/21
08:47
$ECON

Economic Data

/

+

 
ShowHide Related Items >><<
$ECON Economic Data
/

+

General news
U.S. initial jobless claims dipped -7k to 411k in the week ended June 19 » 08:45
06/24/21
06/24
08:45
06/24/21
08:45
$ECON

Economic Data

/

+

U.S. initial jobless…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

Initiation
C4 Therapeutics initiated with a Buy at Brookline » 08:45
06/24/21
06/24
08:45
06/24/21
08:45
CCCC

C4 Therapeutics

$37.82 /

-0.53 (-1.38%)

Brookline analyst Leah…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CCCC C4 Therapeutics
$37.82 /

-0.53 (-1.38%)

CCCC C4 Therapeutics
$37.82 /

-0.53 (-1.38%)

06/22/21 BMO Capital
C4 Therapeutics price target lowered to $53 from $55 at BMO Capital
06/04/21 H.C. Wainwright
C4 Therapeutics initiated with a Buy at H.C. Wainwright
03/31/21 BMO Capital
C4 Therapeutics initiated with an Outperform at BMO Capital
12/08/20 BMO Capital
C4 Therapeutics price target raised to $45 from $33 at BMO Capital
  • 17
    Jun
  • 02
    Oct
CCCC C4 Therapeutics
$37.82 /

-0.53 (-1.38%)

CCCC C4 Therapeutics
$37.82 /

-0.53 (-1.38%)

Hot Stocks
WisdomTree launches U.S. Growth & Momentum Fund » 08:45
06/24/21
06/24
08:45
06/24/21
08:45
WETF

WisdomTree

$6.18 /

-0.035 (-0.56%)

WisdomTree Investments…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WETF WisdomTree
$6.18 /

-0.035 (-0.56%)

WETF WisdomTree
$6.18 /

-0.035 (-0.56%)

04/15/21 Morgan Stanley
WisdomTree Bitcoin ETP cross-listing could speed up growth, says Morgan Stanley
04/08/21 Morgan Stanley
Morgan Stanley upgrades WisdomTree to Equal Weight on improved growth outlook
04/08/21 Morgan Stanley
WisdomTree upgraded to Equal Weight from Underweight at Morgan Stanley
03/17/21 Northcoast
WisdomTree downgraded to Neutral from Buy at Northcoast
WETF WisdomTree
$6.18 /

-0.035 (-0.56%)

WETF WisdomTree
$6.18 /

-0.035 (-0.56%)

WETF WisdomTree
$6.18 /

-0.035 (-0.56%)

General news
FX Action: The dollar » 08:45
06/24/21
06/24
08:45
06/24/21
08:45
$ECON

Economic Data

/

+

FX Action: The dollar…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

Options
Largest borrow rate increases among liquid names » 08:45
06/24/21
06/24
08:45
06/24/21
08:45
CLOV

Clover Health

$13.83 /

+1.09 (+8.56%)

, GRAY

Graybug Vision

$5.10 /

+0.15 (+3.03%)

, RIOT

Riot Blockchain

$32.48 /

+0.27 (+0.84%)

, BTX

Brooklyn ImmunoTherapeutics

$18.27 /

+1.82 (+11.06%)

, RMO

Romeo Power

$8.68 /

+0.15 (+1.76%)

, YALA

Yalla

$18.32 /

+0.32 (+1.78%)

, KMPH

KemPharm

$14.31 /

+0.22 (+1.56%)

, BNGO

Bionano Genomics

$7.25 /

+0.135 (+1.90%)

, LAZR

Luminar

$22.41 /

+0.32 (+1.45%)

, BFI

BurgerFi

$10.22 /

+0.03 (+0.29%)

Latest data shows the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CLOV Clover Health
$13.83 /

+1.09 (+8.56%)

GRAY Graybug Vision
$5.10 /

+0.15 (+3.03%)

RIOT Riot Blockchain
$32.48 /

+0.27 (+0.84%)

BTX Brooklyn ImmunoTherapeutics
$18.27 /

+1.82 (+11.06%)

RMO Romeo Power
$8.68 /

+0.15 (+1.76%)

YALA Yalla
$18.32 /

+0.32 (+1.78%)

KMPH KemPharm
$14.31 /

+0.22 (+1.56%)

BNGO Bionano Genomics
$7.25 /

+0.135 (+1.90%)

LAZR Luminar
$22.41 /

+0.32 (+1.45%)

BFI BurgerFi
$10.22 /

+0.03 (+0.29%)

CLOV Clover Health
$13.83 /

+1.09 (+8.56%)

06/10/21 BofA
Clover Health downgraded to Underperform from Neutral at BofA
05/18/21 Citi
Clover Health price target lowered to $10 from $13 at Citi
05/17/21 BofA
Clover Health downgraded to Neutral at BofA after guidance cut
05/17/21 BofA
Clover Health downgraded to Neutral from Buy at BofA
GRAY Graybug Vision
$5.10 /

+0.15 (+3.03%)

05/13/21
Fly Intel: Top five analyst downgrades
05/13/21 Cantor Fitzgerald
Graybug Vision price target lowered to $6 from $14 at Cantor Fitzgerald
05/13/21 Needham
Graybug Vision downgraded to Hold from Buy at Needham
05/12/21 SVB Leerink
Graybug Vision downgraded to Market Perform from Outperform at SVB Leerink
RIOT Riot Blockchain
$32.48 /

+0.27 (+0.84%)

06/21/21 Compass Point
Compass Point starts Riot Blockchain at Buy after 'transformational' deal
06/21/21 Compass Point
Riot Blockchain initiated with a Buy at Compass Point
06/01/21 B. Riley
Riot Blockchain deal closing 'major positive' for shares, says B. Riley
06/01/21 H.C. Wainwright
Riot Blockchain price target raised to $40 from $30 at H.C. Wainwright
BTX Brooklyn ImmunoTherapeutics
$18.27 /

+1.82 (+11.06%)

RMO Romeo Power
$8.68 /

+0.15 (+1.76%)

05/14/21 BTIG
Romeo Power price target lowered to $15 from $30 at BTIG
03/31/21 Williams Capital
Williams downgrades Romeo Power after 'terrible' first earnings call
03/31/21 BTIG
Romeo Power price target lowered to $30 from $40 at BTIG
03/31/21 Williams Capital
Romeo Power downgraded to Hold from Buy at Williams Trading
YALA Yalla
$18.32 /

+0.32 (+1.78%)

03/12/21 Oppenheimer
Yalla upgraded to Outperform from Perform at Oppenheimer
03/12/21 Oppenheimer
Yalla upgraded to Outperform from Perform at Oppenheimer
12/10/20 Oppenheimer
Yalla initiated with a Perform on valuation at Oppenheimer
12/10/20 Oppenheimer
Yalla initiated with a Perform at Oppenheimer
KMPH KemPharm
$14.31 /

+0.22 (+1.56%)

05/26/21 Roth Capital
Orange Book lists 6 KemPharm SDX patents, confirms as an NCE, says Roth Capital
03/04/21 H.C. Wainwright
KemPharm downgraded to Neutral from Buy at H.C. Wainwright
01/25/21 Roth Capital
KemPharm initiated with a Buy at Roth Capital
BNGO Bionano Genomics
$7.25 /

+0.135 (+1.90%)

06/16/21 BTIG
Bionano Genomics initiated with a Buy at BTIG
02/08/21 Oppenheimer
Bionano Genomics price target raised to $15 from $1.50 at Oppenheimer
01/26/21 Ladenburg
Bionano Genomics price target raised to $14 from $1.25 at Ladenburg
01/22/21 Maxim
Bionano Genomics price target raised to $14 from $2 at Maxim
LAZR Luminar
$22.41 /

+0.32 (+1.45%)

05/25/21 Berenberg
Luminar initiated with a Hold at Berenberg
04/20/21 BofA
Luminar initiated with a Neutral at BofA
04/20/21 BofA
Luminar initiated with a Neutral at BofA
03/24/21 UBS
Apple recently granted patent for LiDAR system, says UBS
BFI BurgerFi
$10.22 /

+0.03 (+0.29%)

CLOV Clover Health
$13.83 /

+1.09 (+8.56%)

GRAY Graybug Vision
$5.10 /

+0.15 (+3.03%)

RIOT Riot Blockchain
$32.48 /

+0.27 (+0.84%)

RMO Romeo Power
$8.68 /

+0.15 (+1.76%)

BNGO Bionano Genomics
$7.25 /

+0.135 (+1.90%)

LAZR Luminar
$22.41 /

+0.32 (+1.45%)

BFI BurgerFi
$10.22 /

+0.03 (+0.29%)

  • 20
    Jan
  • 08
    Jan
  • 30
    Sep
  • 25
    Sep
CLOV Clover Health
$13.83 /

+1.09 (+8.56%)

RIOT Riot Blockchain
$32.48 /

+0.27 (+0.84%)

YALA Yalla
$18.32 /

+0.32 (+1.78%)

LAZR Luminar
$22.41 /

+0.32 (+1.45%)

CLOV Clover Health
$13.83 /

+1.09 (+8.56%)

RIOT Riot Blockchain
$32.48 /

+0.27 (+0.84%)

BTX Brooklyn ImmunoTherapeutics
$18.27 /

+1.82 (+11.06%)

RMO Romeo Power
$8.68 /

+0.15 (+1.76%)

YALA Yalla
$18.32 /

+0.32 (+1.78%)

KMPH KemPharm
$14.31 /

+0.22 (+1.56%)

BNGO Bionano Genomics
$7.25 /

+0.135 (+1.90%)

LAZR Luminar
$22.41 /

+0.32 (+1.45%)

CLOV Clover Health
$13.83 /

+1.09 (+8.56%)

GRAY Graybug Vision
$5.10 /

+0.15 (+3.03%)

RIOT Riot Blockchain
$32.48 /

+0.27 (+0.84%)

BTX Brooklyn ImmunoTherapeutics
$18.27 /

+1.82 (+11.06%)

RMO Romeo Power
$8.68 /

+0.15 (+1.76%)

YALA Yalla
$18.32 /

+0.32 (+1.78%)

KMPH KemPharm
$14.31 /

+0.22 (+1.56%)

BNGO Bionano Genomics
$7.25 /

+0.135 (+1.90%)

LAZR Luminar
$22.41 /

+0.32 (+1.45%)

BFI BurgerFi
$10.22 /

+0.03 (+0.29%)

General news
U.S. durable goods orders bounced 2.3% in May » 08:45
06/24/21
06/24
08:45
06/24/21
08:45
$ECON

Economic Data

/

+

U.S. durable goods orders…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

Hot Stocks
Assure Holdings supports auditory brainstem implant surgery » 08:44
06/24/21
06/24
08:44
06/24/21
08:44
ARHH

Assure Holdings

$1.80 /

+0.04 (+2.27%)

Assure Holdings announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ARHH Assure Holdings
$1.80 /

+0.04 (+2.27%)

ARHH Assure Holdings
$1.80 /

+0.04 (+2.27%)

Hot Stocks
GreenBox selected by TBAS as its exclusive payment technology partner » 08:43
06/24/21
06/24
08:43
06/24/21
08:43
GBOX

GreenBox

$12.81 /

+0.66 (+5.43%)

GreenBox announced a new…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GBOX GreenBox
$12.81 /

+0.66 (+5.43%)

  • 17
    Feb
GBOX GreenBox
$12.81 /

+0.66 (+5.43%)

GBOX GreenBox
$12.81 /

+0.66 (+5.43%)

GBOX GreenBox
$12.81 /

+0.66 (+5.43%)

Hot Stocks
Staffing 360 Solutions announces $10M PPP loan forgiveness » 08:43
06/24/21
06/24
08:43
06/24/21
08:43
STAF

Staffing 360 Solutions

/

+

As recently reported, the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
STAF Staffing 360 Solutions
/

+

STAF Staffing 360 Solutions
/

+

05/19/21 Greenridge
Staffing 360 Solutions price target lowered to $2.50 from $3.50 at Greenridge
STAF Staffing 360 Solutions
/

+

  • 10
    Feb
  • 24
    Dec
Recommendations
Vertex repurchasing up to 3% of outstanding shares, says Piper Sandler » 08:42
06/24/21
06/24
08:42
06/24/21
08:42
VRTX

Vertex Pharmaceuticals

$187.52 /

-1.35 (-0.71%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VRTX Vertex Pharmaceuticals
$187.52 /

-1.35 (-0.71%)

VRTX Vertex Pharmaceuticals
$187.52 /

-1.35 (-0.71%)

06/14/21 Truist
Vertex Pharmaceuticals price target raised to $331 from $305 at Truist
06/14/21 SVB Leerink
Vertex Pharmaceuticals price target lowered to $200 from $250 at SVB Leerink
06/14/21 Deutsche Bank
Grifols upgraded to Buy from Hold at Deutsche Bank
06/13/21 Piper Sandler
Vertex Pharmaceuticals price target lowered to $261 from $347 at Piper Sandler
VRTX Vertex Pharmaceuticals
$187.52 /

-1.35 (-0.71%)

VRTX Vertex Pharmaceuticals
$187.52 /

-1.35 (-0.71%)

VRTX Vertex Pharmaceuticals
$187.52 /

-1.35 (-0.71%)

VRTX Vertex Pharmaceuticals
$187.52 /

-1.35 (-0.71%)

Hot Stocks
Staffing 360 Solutions expects positive net income in Q2 » 08:42
06/24/21
06/24
08:42
06/24/21
08:42
STAF

Staffing 360 Solutions

/

+

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
STAF Staffing 360 Solutions
/

+

STAF Staffing 360 Solutions
/

+

05/19/21 Greenridge
Staffing 360 Solutions price target lowered to $2.50 from $3.50 at Greenridge
STAF Staffing 360 Solutions
/

+

  • 10
    Feb
  • 24
    Dec
Recommendations
Arcus Biosciences price target raised to $63 from $53 at SVB Leerink » 08:42
06/24/21
06/24
08:42
06/24/21
08:42
RCUS

Arcus Biosciences

$23.40 /

+0.67 (+2.95%)

SVB Leerink analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RCUS Arcus Biosciences
$23.40 /

+0.67 (+2.95%)

RCUS Arcus Biosciences
$23.40 /

+0.67 (+2.95%)

02/25/21 Barclays
Arcus Biosciences price target raised to $45 from $40 at Barclays
02/25/21 Mizuho
Arcus Biosciences price target raised to $43 from $40 at Mizuho
01/20/21 Citi
Arcus Biosciences price target raised to $51 from $32 at Citi
01/19/21 Wedbush
Arcus Biosciences price target raised to $55 from $48 at Wedbush
RCUS Arcus Biosciences
$23.40 /

+0.67 (+2.95%)

RCUS Arcus Biosciences
$23.40 /

+0.67 (+2.95%)

Syndicate
XPeng to offer 85M Class A shares in global offering » 08:42
06/24/21
06/24
08:42
06/24/21
08:42
XPEV

XPeng

$41.58 /

+1.64 (+4.11%)

XPeng announced in a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XPEV XPeng
$41.58 /

+1.64 (+4.11%)

XPEV XPeng
$41.58 /

+1.64 (+4.11%)

06/07/21 Wedbush
Wedbush remains 'firmly bullish' on Tesla, EV thesis despite speed bumps
06/02/21 Citi
XPeng price target raised to $50.30 from $50 at Citi
05/25/21 Nomura
XPeng initiated with a Buy at Nomura
05/11/21 Wedbush
Tesla April China deliveries see some softness, China tensions key, says Wedbush
XPEV XPeng
$41.58 /

+1.64 (+4.11%)

  • 09
    Dec
  • 27
    Aug
XPEV XPeng
$41.58 /

+1.64 (+4.11%)

XPEV XPeng
$41.58 /

+1.64 (+4.11%)

XPEV XPeng
$41.58 /

+1.64 (+4.11%)

Recommendations
IHS Markit price target raised to $105 from $100 at Truist » 08:42
06/24/21
06/24
08:42
06/24/21
08:42
INFO

IHS Markit

$110.49 /

-1.13 (-1.01%)

, SPGI

S&P Global

$400.64 /

-3.63 (-0.90%)

Truist analyst Andrew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
INFO IHS Markit
$110.49 /

-1.13 (-1.01%)

SPGI S&P Global
$400.64 /

-3.63 (-0.90%)

INFO IHS Markit
$110.49 /

-1.13 (-1.01%)

06:55 Today BMO Capital
IHS Markit price target raised to $121 from $110 at BMO Capital
06:50 Today Deutsche Bank
IHS Markit price target raised to $123 from $118 at Deutsche Bank
04/27/21 Baird
S&P Global initiated with an Outperform at Baird
04/14/21 BMO Capital
IHS Markit price target raised to $110 from $96 at BMO Capital
SPGI S&P Global
$400.64 /

-3.63 (-0.90%)

04/29/21 Deutsche Bank
S&P Global initiated with a Buy at Deutsche Bank
04/27/21
Fly Intel: Top five analyst initiations
04/27/21 Baird
S&P Global initiated with an Outperform at Baird
04/14/21 BMO Capital
IHS Markit price target raised to $110 from $96 at BMO Capital
INFO IHS Markit
$110.49 /

-1.13 (-1.01%)

SPGI S&P Global
$400.64 /

-3.63 (-0.90%)

  • 11
    May
INFO IHS Markit
$110.49 /

-1.13 (-1.01%)

SPGI S&P Global
$400.64 /

-3.63 (-0.90%)

SPGI S&P Global
$400.64 /

-3.63 (-0.90%)

Hot Stocks
Ageagle Aerial Systems expands HempOverview licensing agreement with Florida » 08:41
06/24/21
06/24
08:41
06/24/21
08:41
UAVS

Ageagle Aerial Systems

$5.45 /

+0.32 (+6.24%)

AgEagle Aerial Systems…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UAVS Ageagle Aerial Systems
$5.45 /

+0.32 (+6.24%)

UAVS Ageagle Aerial Systems
$5.45 /

+0.32 (+6.24%)

UAVS Ageagle Aerial Systems
$5.45 /

+0.32 (+6.24%)

UAVS Ageagle Aerial Systems
$5.45 /

+0.32 (+6.24%)

UAVS Ageagle Aerial Systems
$5.45 /

+0.32 (+6.24%)

Earnings
Staffing 360 Solutions expects Q2 revenue in excess of $52M, one est. $51.52M » 08:41
06/24/21
06/24
08:41
06/24/21
08:41
STAF

Staffing 360 Solutions

/

+

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
STAF Staffing 360 Solutions
/

+

STAF Staffing 360 Solutions
/

+

05/19/21 Greenridge
Staffing 360 Solutions price target lowered to $2.50 from $3.50 at Greenridge
STAF Staffing 360 Solutions
/

+

  • 10
    Feb
  • 24
    Dec
Hot Stocks
ViewRay receives order for up to 14 MRIdian Systems from GenesisCare » 08:40
06/24/21
06/24
08:40
06/24/21
08:40
VRAY

ViewRay

$5.92 /

+0.1 (+1.72%)

ViewRay announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VRAY ViewRay
$5.92 /

+0.1 (+1.72%)

VRAY ViewRay
$5.92 /

+0.1 (+1.72%)

06/14/21 Piper Sandler
ViewRay shares should attract more investor interest, says Piper Sandler
05/07/21 Guggenheim
ViewRay upgraded to Buy from Neutral at Guggenheim
03/26/21 BTIG
ViewRay upgraded to Buy from Neutral at BTIG
01/12/21 Piper Sandler
ViewRay price target raised to $7 from $4 at Piper Sandler
VRAY ViewRay
$5.92 /

+0.1 (+1.72%)

  • 22
    Jan
  • 05
    Jan
VRAY ViewRay
$5.92 /

+0.1 (+1.72%)

Upgrade
Intersect ENT upgraded to Outperform from Market Perform at SVB Leerink » 08:40
06/24/21
06/24
08:40
06/24/21
08:40
XENT

Intersect ENT

$15.97 /

-0.3 (-1.84%)

SVB Leerink analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XENT Intersect ENT
$15.97 /

-0.3 (-1.84%)

XENT Intersect ENT
$15.97 /

-0.3 (-1.84%)

08:02 Today SVB Leerink
Intersect ENT upgraded to Outperform from Market Perform at SVB Leerink
05/18/21 Piper Sandler
Piper says Intersect ENT positioned to hit international goal with CE Marks back
03/09/21 Piper Sandler
Piper says Intersect ENT FY21 guidance 'potentially on the conservative side'
01/15/21 Piper Sandler
Intersect ENT price target raised to $23 from $17 at Piper Sandler
XENT Intersect ENT
$15.97 /

-0.3 (-1.84%)

Hot Stocks
Five Below expands partnership with Instacart nationally » 08:39
06/24/21
06/24
08:39
06/24/21
08:39
FIVE

Five Below

$195.43 /

+2.32 (+1.20%)

Five Below announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FIVE Five Below
$195.43 /

+2.32 (+1.20%)

FIVE Five Below
$195.43 /

+2.32 (+1.20%)

06/23/21 R5 Capital
R5 Capital sees earnings 'tailwind' for Five Below, starts with Buy
06/23/21 R5 Capital
Five Below initiated with a Buy at R5 Capital
06/04/21 RBC Capital
Five Below price target raised to $234 from $225 at RBC Capital
06/04/21 Jefferies
Five Below price target raised to $300 from $260 at Jefferies
FIVE Five Below
$195.43 /

+2.32 (+1.20%)

FIVE Five Below
$195.43 /

+2.32 (+1.20%)

Hot Stocks
Vertex authorizes $1.5B buyback of shares through end of 2022 » 08:39
06/24/21
06/24
08:39
06/24/21
08:39
VRTX

Vertex Pharmaceuticals

$187.52 /

-1.35 (-0.71%)

Vertex Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VRTX Vertex Pharmaceuticals
$187.52 /

-1.35 (-0.71%)

VRTX Vertex Pharmaceuticals
$187.52 /

-1.35 (-0.71%)

06/14/21 Truist
Vertex Pharmaceuticals price target raised to $331 from $305 at Truist
06/14/21 SVB Leerink
Vertex Pharmaceuticals price target lowered to $200 from $250 at SVB Leerink
06/14/21 Deutsche Bank
Grifols upgraded to Buy from Hold at Deutsche Bank
06/13/21 Piper Sandler
Vertex Pharmaceuticals price target lowered to $261 from $347 at Piper Sandler
VRTX Vertex Pharmaceuticals
$187.52 /

-1.35 (-0.71%)

VRTX Vertex Pharmaceuticals
$187.52 /

-1.35 (-0.71%)

VRTX Vertex Pharmaceuticals
$187.52 /

-1.35 (-0.71%)

VRTX Vertex Pharmaceuticals
$187.52 /

-1.35 (-0.71%)

Hot Stocks
Sellas Life Sciences reports updated data from mesothelioma study of GPS » 08:38
06/24/21
06/24
08:38
06/24/21
08:38
SLS

Sellas Life Sciences

$13.34 /

+1.51 (+12.76%)

SELLAS Life Sciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SLS Sellas Life Sciences
$13.34 /

+1.51 (+12.76%)

SLS Sellas Life Sciences
$13.34 /

+1.51 (+12.76%)

06/03/21 Alliance Global Partners
Sellas Life Sciences price target raised to $16.50 from $8 at Alliance Global Partners
02/09/21 Maxim
Heat data puts cancer vaccine discussion 'back on the table,' says Maxim
12/21/20 Alliance Global Partners
Alliance Global Partners keeps Buy on Sellas following data from trials

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.